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new  domains  were  progressively  added  to  cytoplasmic  aminoacyl  transfer  RnA  (tRnA) 
synthetases during evolution. one example is the unE-s domain, appended to seryl-tRnA   
synthetase (serRs) in species that developed closed circulatory systems. Here we show using 
solution and crystal structure analyses and in vitro and in vivo functional studies that unE-s   
harbours  a  robust  nuclear  localization  signal  (nLs)  directing  serRs  to  the  nucleus  where 
it  attenuates  vascular  endothelial  growth  factor  A  expression.  We  also  show  that  serRs 
mutants previously linked to vasculature abnormalities either deleted the nLs or have the nLs 
sequestered in an alternative conformation. A structure-based second-site mutation, designed 
to release the sequestered nLs, restored normal vasculature. Thus, the essential function 
of serRs in vascular development depends on unE-s. These results are the first to show an 
essential role for a tRnA synthetase-associated appended domain at the organism level, and 
suggest that acquisition of unE-s has a role in the establishment of the closed circulatory 
systems of vertebrates. 
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A
minoacyl  transfer  RNA  (tRNA)  synthetases  (aaRSs)  are 
enzymes essential for translation throughout the three king-
doms of life1,2. Each member of the tRNA synthetase family 
is responsible for charging one specific amino acid onto its cognate 
tRNA. Once the tRNA is charged and delivered to the ribosome, 
the amino acid can be transferred from the tRNA onto a growing 
peptide according to the genetic code. During the evolution of this 
ancient protein family, new domains and motifs were progressively 
added to aaRSs to expand their functionalities3–6. These appended 
domains, often dispensable for aminoacylation, are considered as 
markers  for  the  aaRS-associated  functions  beyond  translation6. 
Although their appearance correlates with the increase of biologi-
cal complexity in higher organisms, the functional significance of 
these aaRS-associated appended domains is not understood at the 
organism level.
With  this  question  in  mind,  we  recently  identified  a  unique 
domain (named UNE-S) at the carboxyl-terminus of seryl-tRNA 
synthetase (SerRS) in all vertebrates from fish to humans6. Interest-
ingly, three independent forward-genetic studies in zebrafish sug-
gested a role for SerRS in vascular development7–9. Disruption of 
the gene encoding the cytoplasmic SerRS by insertional mutagen-
esis results in a null mutation, and causes abnormal blood vessel for-
mation and defective blood circulation in the embryo7. Separately, 
two  additional  studies  identified  three  N-ethyl-N-nitrosourea-
induced mutations in SerRS that also cause vasculature defects8,9. 
Two of these mutations result in premature stop codons (Q402Stop 
and E421Stop) eliminating part of the aminoacylation domain and 
the entire UNE-S domain, while the third is a missense mutation 
(F383V) located in the aminoacylation domain and allows expres-
sion of the full enzyme. Microinjection of either human or zebrafish 
SerRS  messenger  RNA  (mRNA)  into  ko095  (Q402Stop)  mutant 
zebrafish  embryos  rescued  the  vascular  phenotype,  indicating 
that the vascular role of SerRS is conserved between zebrafish and 
humans8. Interestingly, an aminoacylation-defective SerRS (T429A 
SerRS) mRNA could also restore the vasculature phenotype, sug-
gesting that the role of SerRS in vasculature development is inde-
pendent of aminoacylation8. This noncanonical activity of SerRS 
was linked to the expression of vegfa, the gene encoding vascular 
endothelial growth factor A (VEGFA), a key regulator of angiogen-
esis and vasculogenesis8.
Considering  that  UNE-S  was  joined  to  SerRS  at  the  time  of 
development of the closed circulatory system, we speculated that 
UNE-S is relevant to the noncanonical role of SerRS in vascular 
development. In this study, we identified a nuclear localization sig-
nal (NLS) sequence embedded in UNE-S, and designed a series of 
experiments to demonstrate that the essential role of SerRS in vas-
cular development is dependent on UNE-S and its role to mobilize 
SerRS from the cytoplasm to the nucleus.
Results
UNE-S-dependent nuclear localization of SerRS. From inspection 
of  UNE-S,  we  identified  a  KKQKKQXEXXKKK  sequence  as  a 
putative NLS sequence that is highly conserved in all vertebrates 
(Fig. 1). This observation raised the possibility that, in addition to 
being present in the cytoplasm for protein synthesis, SerRS might 
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Figure 1 | Domain structure of vertebrate SerRS and the appearance 
of the UNE-S domain during evolution. mutations causing vasculature 
abnormalities in zebrafish are labelled on top of the domain structure. 
The sequence segments D378-F383 and F470-A514 of human serRs are 
aligned with the same regions from other vertebrates and non-vertebrates 
serRs sequences. The predicted nuclear localization signal sequence (nLs) 
embedded in the unE-s domain is highlighted in blue. 
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Figure 2 | Nuclear localization of SerRS. (a) Confocal immunofluorescence microscopy showing the nuclear localization of the endogenous serRs 
in HuVECs. The green signal corresponds to serRs staining, whereas the blue corresponds to nuclear 4,6-diamidino-2-phenylindole (DAPI) staining. 
The picture was taken by confocal microscope in Z-mode. The cross-section at the yellow line is shown at the bottom. Representative serRs nuclear 
localizations are marked with white arrowheads. (b) Cell fractionation assay confirming the nuclear localization of endogenous serRs in both HuVEC 
and HEK 293 T cells. nuclear (n) and cytoplasmic (C) extracts were analysed by western blot analysis. serRs was detected by custom-made anti-serRs 
antibody. Lamin A/C and α-tubulin were used as nuclear and cytoplasmic markers, respectively. (c) Confocal immunofluorescence microscopy showing 
that the nLs in unE-s domain can facilitate the nuclear import of GFP protein in HEK 293 T and in HeLa cells. GFP protein is fused with the nLs sequence 
from human serRs (GFP–nLs) at the C-terminus. The green signal corresponds to GFP or GFP–nLs, whereas the blue corresponds to nuclear DAPI 
staining. scale bars in this figure correspond to 20 µm.ARTICLE     
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also be distributed to the nucleus. Confocal immunofluorescence 
microscopy demonstrated nuclear localization of SerRS in human 
endothelial  cells  (that  is,  HUVECs)  (Fig.  2a).  Cell  fractionation 
analysis  further  confirmed  the  nuclear  distribution  of  SerRS  in 
HUVECs  (Fig.  2b).  Nuclear  distribution  of  endogenous  SerRS 
was also detected in HEK 293 T cells (Fig. 2b), indicating that the 
mechanism for bringing SerRS into the nucleus is not restricted 
to endothelial cells. We estimated that for both cell types, ~10% of 
cellular SerRS is located in the nucleus based on our western blot 
analysis (Fig. 2b).
The potential NLS in UNE-S has the profile of a bipartite locali-
zation signal with two stretches of positively charged lysines that 
could be recognized by a nuclear transport protein10,11. To test 
its authenticity as an NLS, we added the corresponding sequence 
from human SerRS (482KKQKKQHEGSKKK494) to the carboxyl-
terminus of the green fluorescent protein (GFP). The GFP–NLS 
fusion protein, when expressed in HeLa or HEK 293 T cells, pre-
dominantly  localized  to  the  nucleus  (Fig.  2c).  In  contrast,  the 
native GFP protein localized both to the nucleus and to the cytosol.   
These results show that the predicted NLS sequence in UNE-S is 
sufficient to direct nuclear localization.
To  establish  whether  the  482KKQKKQHEGSKKK494  NLS 
sequence is necessary for nuclear localization of SerRS, we deleted 
or mutated the NLS and compared the nuclear localization of the 
mutants with that of wild-type (WT) SerRS. As expected, the trans-
fected WT protein was distributed in the nucleus of HEK 293 T cells 
(Fig. 3a). We then created two deletion mutations that removed either 
the entire UNE-S (∆470-514) or only the region from the NLS to the 
C-terminus (∆482-514). In contrast to the WT SerRS, both deletion 
constructs only appeared in the cytoplasm and had no detectable 
nuclear distribution (Fig. 3a). We also created mutants that replace 
lysine residues in the NLS with alanines. As the number of lysine 
substitutions increased, the amount of SerRS nuclear localization 
decreased. A single lysine mutant K493A had a slightly reduced 
nuclear localization (data not shown), but only trace amounts of 
the  triple  mutant  K482A/K485A/K493A  (designated  as  NLSmut) 
were detected in the nucleus (Fig. 3a). These results strongly suggest 
that the predicted bipartite NLS in UNE-S is critical for the nuclear 
localization of SerRS.
SerRS mutants are defective in nuclear localization. Among the 
three different mutations in the SerRS gene (SARS) that are linked 
to zebrafish vasculature abnormalities, two were nonsense muta-
tions resulting in a premature stop codon after Y401 or V4208,9 
yielding  C-terminal  truncated  SerRS  proteins  lacking  UNE-S 
(Fig. 1). Based on our data above, neither of these truncated pro-
teins would be localized to the nucleus. The question remains on 
the third mutation, which results in a F383V substitution that is 
located ~100 amino acids upstream of the NLS. Interestingly, this 
F383V substitution completely abolishes nuclear localization of 
SerRS (Fig. 3b). Thus, all three SerRS mutations linked to vascu-
lature abnormalities in zebrafish would result in defective nuclear 
localization of SerRS. In contrast, the aminoacylation-defective 
T429A SerRS, which rescued the abnormal vascular phenotype, 
localizes to the nucleus as efficient as WT SerRS (Fig. 3c). The 
correlation  between  vasculature  abnormality  and  the  lack  of 
SerRS nuclear localization strongly suggests that the role of SerRS 
in  vascular  development  is  dependent  on  the  NLS  embedded   
in UNE-S.
Crystal  structure  analysis  of  human  SerRS.  To  understand 
how  F383V  affects  nuclear  localization,  we  determined  the 
  crystal structure of human SerRS at 2.9 Å resolution (Fig. 4a and   
Supplementary Table S1). The human protein shares overall 81% 
sequence identity with the fish ortholog, and F383 is a strictly 
conserved residue from fish to humans (Fig. 1 and Supplementary 
Fig. S1). Three independent homodimers of SerRS were found in 
the asymmetric unit of the crystal. While the conformation of the 
aminoacylation domain is almost the same for all three dimers in 
the asymmetric unit, the N-terminal tRNA-binding domains have 
more  flexible  structures  (Fig.  4b).  Interestingly,  the  C-terminal 
UNE-S domain (including the NLS) was mostly disordered in all 
six subunits, suggesting a dynamic conformation of the NLS that 
would enhance its accessibility to the nuclear transport machinery. 
F383 is located near the end of a β-strand (β10) that is part of the 
core seven-stranded antiparallel β-sheet (β1–β9–β10–β11–β13–
β8–β7) of the aminoacylation domain, and spatially close to the 
active site and the flexible NLS (Fig. 4a,c). The side chain of F383 
forms hydrophobic interactions with H170 and F316 to stabilize 
the β10–β11 hairpin as part of the central core (Fig. 4c). A stereo 
image of the electron density map surrounding F383 is shown in 
Figure 4d. We speculated that the F383V substitution would desta-
bilize the hydrophobic core and, in some way, create an internal 
binding site for the NLS. As a result, the NLS would become less 
accessible, as illustrated in Figure 4c, and less able to facilitate 
nuclear localization.
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Figure 3 | UNE-S-dependent SerRS nuclear localization and its disruption 
by a mutation linked to vasculature abnormality. (a) Cell fractionation 
and mutagenesis studies showing that the predicted nLs within the unE-
s domain is responsible for the nuclear localization of serRs. subcellular 
localizations of the exogenously expressed serRs proteins were detected 
by anti-flag tag polyclonal antibody. Deletion of the whole unE-s domain 
(∆470-514) or deletion from the nLs (∆482-514) abolished the nuclear 
localization of serRs. Triple point mutation within the nLs (K482A/
K485A/K493A, designated as nLsmut) significantly reduced the nuclear 
localization. (b) Cell fractionation analysis demonstrating that the F383V 
mutant linked to vasculature abnormality in zebrafish is defective in nuclear 
localization. (c) Cell fractionation analysis confirms the intact nuclear 
localization of T429A serRs.ARTICLE
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Solution structure shows the effect of F383V on UNE-S. To com-
pare the conformational dynamics of the NLS between the WT 
and  F383V  SerRS  in  solution,  we  carried  out  hydrogen–deute-
rium exchange analysis monitored by mass spectrometry (HDX-
MS). The rate and level of hydrogen–deuterium exchange of each 
digested peptide throughout the protein are directly related to its 
local  conformation:  more  solvent-accessible  and  less  H-bonded 
peptides exhibit faster and greater deuterium exchange than less 
solvent-accessible and more H-bonded ones12. The SerRS proteins 
in this work exhibited the EX2 exchange regime, which is typical for 
most proteins in physiological conditions. By comparing the level 
of  hydrogen–deuterium  exchange  of  the  same  peptide  segments 
in the WT and F383V SerRS, a difference map was constructed   
(Supplementary Fig. S2).
The peptide covering the F383V mutation site (E380-L392) is 
the only area on the protein that exhibits a dramatic increase in 
HDX (41% over WT SerRS) (Supplementary Fig. S2 and Fig. 5a), 
presumably because of the weakened hydrophobic core caused by 
the mutation. Remarkably, also as a result of the F383V mutation, 
the NLS region shows the most dramatic decrease in HDX (64%  
below WT SerRS), indicating that it is stabilized in the mutant. This 
result is consistent with our hypothesis that the NLS becomes less 
accessible in the F383V mutant (Figs 4c and 5a).
Structure-based design of second-site revertant of F383V. We 
next wanted to determine the F383V-induced internal binding site 
for the NLS. By analysing the surface electrostatic potential of SerRS, 
three negatively charged sites were identified as potential binding 
sites for the positively charged NLS. Those sites are spatially adjacent 
to both the F383V mutation site and the partially resolved UNE-S 
in the crystal structure. As shown in Supplementary Figure S3a,b,   
site I contains four negatively charged residues (D148, E149, E150 
and D152), site II contains D178, E181 and E183, while site III 
contains D378, E380 and E391. Among them, site III is the closest 
to the F383V mutation site (Supplementary Fig. S3b). If some of 
those negatively charged residues are important for NLS binding, 
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their substitution with neutral or positively charged residues would 
release the NLS and restore nuclear localization.
To identify the NLS-binding site on F383V SerRS, we created 
mutations within each site (I or II or III) on top of the F383V back-
ground. While mutations within sites I and II did not have any effect 
on nuclear localization (Supplementary Fig. S3c), a double mutation 
within site III (D378S/E380G) partially rescued the nuclear locali-
zation defect of F383V (Supplementary Fig. S3c). The rescue effect 
was mostly contributed by the D378S mutation alone, while substi-
tution of D378 with a positively charged arginine provided further 
rescue (Fig. 5b). These results suggest that D378 has a major role 
in tethering the NLS in F383V SerRS, and that this tethering effect 
is largely dependent on electrostatic interactions. Consistently, as 
a result of the NLS binding, the D378-containing peptide (V365-
D378) exhibited a 23% decrease in HDX in F383V SerRS relative to 
the WT protein (Fig. 5a). Possibly, as the F383V mutation increases 
the conformational dynamics of the loop region of the β10–β11 
hairpin (Fig. 5a), a binding groove is opened up near the hydropho-
bic core to accommodate the NLS that is then tethered by D378.
UNE-S is dispensable for SerRS aminoacylation. Previous studies 
showed that the vasculature defect in zebrafish was rescued by the 
expression of an enzymatically inactive SerRS. This result suggested 
that the role of SerRS in vascular development is separate from its role 
in protein synthesis. Therefore, the NLS, if related to vascular devel-
opment, might not be involved in the enzymatic activity of SerRS. To 
investigate this point, we studied the two-step aminoacylation reac-
tion. In the first step, serine is condensed with ATP to from seryl-
adenylate (Ser-AMP). In the second step, serine is transferred from 
Ser-AMP to tRNASer. Using standard assays, we showed that, indeed, 
mutation or deletion of the UNE-S did not affect either of the two steps 
of the aminoacylation reaction (Fig. 5c and Supplementary Table S2).
However, the F383V mutation reduced the catalytic activity of 
SerRS (Fig. 5c). This might be due to the proximity of F383 to the 
active site, and the disturbance to the hydrophobic core next to the 
active site caused by the F to V substitution, as seen in the HDX 
experiment (Fig. 5a). Remarkably, deletion of the NLS, which had 
no effect on the aminoacylation activity of WT SerRS, completely 
abolished the residual enzymatic activity of F383V SerRS (Fig. 5c). 
The second-site mutation D378R, which reverts the nuclear locali-
zation defect of F383V, also completely abolished the enzymatic 
activity  of  F383V  SerRS.  These  observations  further  support  a 
strong interplay between the NLS and D378 in the F383V mutant. 
Presumably, through the interaction with D378, the NLS helps to 
partially restore the destabilized active site resulting from the F383V 
mutation. Removal of this interaction, either by deletion of the NLS 
or by mutation of D378, abrogates the restoration effect.
Role of UNE-S in vascular development in the zebrafish. To con-
firm a functional link between the NLS and vascular development 
in a vertebrate model, we tested the rescue of vascular abnormality 
in zebrafish by various SerRS mutants. A fish model for vasculature 
abnormalities  was  created  by  injecting  an  antisense  morpholino 
(MO) directed against SerRS8. Consistent with the previous report 
by Fukui et al.8, we show that injection of SerRS-MO results in 
abnormal intersegmental vessel (ISV) branching in 50.8% (n = 96 
out of 189) of morphants, in contrast to 1.4% (n = 3 out of 207) in 
uninjected controls (Fig. 6a and Table 1). Co-injection of human 
SerRS mRNA efficiently rescued the abnormal ISV branching (8.4%; 
n = 16 out of 190) in SerRS morphants (Fig. 6a and Table 1).
In  contrast,  ∆482-514,  NLSmut  and  F383V  SerRS,  which  we 
showed to be defective in nuclear localization (Fig. 3a,b), could not 
rescue the aberrant ISV branching (Fig. 6b,c and Table 1). Abnor-
mal ISV branching was observed in 44.6% (n = 79 out of 177), 51.0% 
b c
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(n = 77 out of 151) and 45.1% (n = 69 out of 153) of SerRS morphants 
injected with ∆482-514, NLSmut and F383V SerRS mRNA, respec-
tively. These results strongly suggested that the NLS introduced by 
UNE-S is essential for vascular development.
To  further  establish  this  conclusion,  the  rationally  designed 
second-site revertant that restores nuclear localization by a com-
pensatory substitution distal to the NLS was tested. Strikingly, the 
double mutant F383V/D378R SerRS mRNA rescued the abnormal 
ISV branching defects (8.5%; n = 13 out of 153) with efficiency com-
parable to that of the WT mRNA (Fig. 6c and Table 1). The result 
further demonstrated the critical link of the NLS and UNE-S with 
vasculature development.
The  critical  role  of  the  NLS  in  the  UNE-S  domain  indicates 
a  specific  function  for  SerRS  in  the  nucleus  of  vertebrate  cells.   
Fukui et al.8 reported that the ko095 SerRS mutant zebrafish had 
increased expression of vegfa, which was suppressed by microin-
jection of the aminoacylation-defective T429A SerRS mRNA, sug-
gesting that the noncanonical role of SerRS is related to negative 
regulation of vegfa expression8. Consistently, Herzog et al.9 showed 
that inhibition of VEGF signalling rescued aberrant dilatation of 
the aortic arch vessels in SerRS mutant zebrafish. To address the 
question of whether the function of SerRS in regulating VEGFA 
was also linked to UNE-S, we examined vegfa mRNA levels in fish 
embryos obtained from our previous experiments. The observed 
vascular abnormality was clearly coincident with upregulation of 
vegfa expression. Compared with the uninjected group, embryos 
injected with the SerRS MO have more than a threefold increase 
in vegfa mRNA level (Fig. 6d). This increase was largely suppressed 
a Uninjected
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ISV
SerRS-MO
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ISV Rescue
SerRS-MO + SerRS mRNA (WT)
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Relative vegfa mRNA level 5
4
3
2
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0
*
*
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Figure 6 | Rescue experiments in zebrafish demonstrating the role of UNE-S in vascular development. (a) Illustration of the phenotype rescue 
experiment in zebrafish. The serRs morpholino (serRs-mo, ~5 ng per embryo) was injected into the yolk of zebrafish embryos (1- to 2-cell stage) 
to produce a model of intersegmental vessel (IsV) abnormality. Co-injection of serRs-mo with the WT human serRs mRnA (~250 pg per embryo) 
rescued the aberrant IsV branching. The IsV development is recorded at 72 h post fertilization and the abnormal IsV branches are indicated by red 
arrows. (b) Co-injection of serRs-mo with the nLs-deleted ∆482-514 or nLsmut human serRs mRnA did not rescue the aberrant IsV branching.  
(c) Co-injection of serRs-mo with F383V human serRs mRnA did not, whereas with F383V/D378R serRs mRnA did, rescue the aberrant IsV 
branching. (d) The effect of serRs nuclear localization on VEGFA transcription. semiquantitative RT–PCR analysis to evaluate vefga mRnA levels in 
72-hpf zebrafish embryos injected with serRs-mo alone or serRs-mo together with WT or mutant human serRs mRnAs. Relative vegfa mRnA levels 
represented as fold increase (mean ± s.e.m., n = 3, *P < 0.05 (student’s t-test)) over uninjected control samples, after normalization to the levels of  
β-actin mRnA. scale bars in this figure correspond to 100 µm.ARTICLE     
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when WT or F383V/D378R SerRS mRNA was co-injected with the 
SerRS MO (Fig. 6d). In contrast, co-injection of nuclear localiza-
tion-defective ∆482-514 or NLSmut or F383V SerRS did not sup-
press vegfa expression. Thus, regulation of vegfa expression was also 
dependent on UNE-S and the nuclear localization of SerRS. This 
observation suggested that the function of SerRS in the nucleus is 
related to VEGFA regulation.
Discussion
Blood vessel formation, or vasculogenesis, is one of the hallmarks 
of vertebrate development. During the invertebrate-to-vertebrate 
transition, the open circulatory systems, where blood is pumped by 
the heart into the body cavities, of invertebrates evolved into the 
advanced closed circulatory systems, where vessels are developed to 
carry the blood to nourish organs and tissues. As the invertebrate-
to-vertebrate transition coincides with the appearance of UNE-S, 
and because UNE-S is shown here to be essential for vascular devel-
opment, acquisition of UNE-S may have a role in the establishment 
of the closed circulatory systems of vertebrates.
It is worth noting that, as the tree of life ascended from bacte-
ria to lower and higher eukaryotes, new domains or motifs were 
added  to  aaRSs  in  a  progressive  and  accretive  manner6.  In  the 
case of SerRSs, the acquisition consists of extensions beyond the   
C-termini  of  the  bacterial  orthologs  (Fig.  1  and  Supplementary 
Fig. S1). SerRSs from basal eukaryotes have short C-terminal exten-
sions that, as shown for Saccharomyces cerevisiae, while appearing 
to be important for stability of the synthetase in vitro and in vivo, 
are dispensable for aminoacylation13. However, in going through 
the transition from invertebrates to vertebrates, the C-terminus of 
SerRS was significantly expanded into the UNE-S domain. While it 
remains not important for aminoacylation (Fig. 5c), the expansion 
included the appearance of a robust NLS.
Our work showed that, because of the NLS brought in by UNE-S, 
this novel appended domain can mobilize SerRS for translocation 
from the cytosol to the nucleus—a function that is orthogonal to 
aminoacylation. Once in the nucleus, SerRS has the additional func-
tion of regulating expression of VEGFA, a key regulator of vascular 
development, most likely at the level of transcription. This nuclear 
activity of SerRS is in some ways reminiscent of the reported activity 
of LysRS, which regulates transcription factors MITF and USF2 that 
alter expression of target genes in response to allergic stimulation14–16.   
From another aspect, the role of nuclear SerRS mirrors that of the 
bifunctional  GluProRS,  which  in  response  to  interferon-gamma 
stimulation,  silences  translation  of  VEGFA  mRNA  in  the  cyto-
plasm17. Thus, an increasing literature has reported the role of aaRSs 
in regulating gene expression. In this regard, the work reported here 
is the first to show how an appended domain mobilizes a synthetase 
for an ex-translational role related to gene transcription.
A lysine-rich peptide derived from a putative NLS sequence at 
the N-terminus of Lupinus luteus GlnRS was shown to interact with 
DNA and was suggested to potentially regulate gene expression18. 
The NLS within the UNE-S domain of SerRS is also lysine-rich and 
has a flexible conformation, as revealed in our crystal structure of 
human SerRS (which is the first structure of a vertebrate SerRS). 
This flexibility was further demonstrated through the UNE-S con-
formational  switch  induced  by  the  F383V  mutation.  As  flexible 
protein motifs are known to adapt by induced fit to specific DNA 
sequence targets, UNE-S may not only mobilize SerRS for nuclear 
localization but also facilitate interactions with potential targets in 
the nucleus.
Given that almost all aaRSs have their own distinct elaborations 
with new domains, our work provides further motivation to dis-
cover and understand the function and significance of other syn-
thetase domain accretions in higher organisms. Among them, the   
N-terminal WHEP domain of TrpRS is of particular interest, because 
it also appears during the transition from invertebrates to vertebrates   
and  has  been  shown  to  regulate  the  anti-angiogenic  activity  of 
human TrpRS19,20.
Methods
Confocal immunofluorescence microscopy. To detect SerRS subcellular localiza-
tion, HUVEC cells were seeded on cover slips and grown overnight. After fixing 
and permeabilization, cells were stained with custom-made rabbit anti-SerRS 
antibody (1 µg ml − 1) followed by Aflex Fluor 488 (green) goat anti-rabbit IgG  
(at 1:1000 dilution) and 4,6-diamidino-2-phenylindole (1 µg ml − 1). The photos of 
the cells were taken with a Bio-Rad (Zeiss) Radiance 2100 Rainbow laser scanning 
confocal microscope in Z-mode (×60 oil objective).
Nuclear fractionation analysis. Human SerRS gene was cloned from HEK293  
T cell by RT–PCR and then inserted into pFLAG-CMV2 vector (Sigma-Aldrich) 
with an N-terminal flag tag. Mutant SerRS constructs were generated by site-
directed mutagenesis and transfected into HEK 293 T cells. Cells were harvested 
after 24 h, and the cytoplasmic and nuclear fractions were separated and extracted 
by using NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific). 
Exogenously expressed SerRS proteins were detected by western blot analysis using 
anti-flag polyclonal antibody (Sigma-Aldrich).
Protein overexpression and crystallization. Human SerRS gene was also cloned 
into pET20b vector (Novagen) with a C-terminal 6×His tag and overexpressed  
in E. coli BL21 (DE3) cells. SerRS protein was purified in tandem by Ni-NTA  
affinity (Qiagen) and HiLoad 26/10 Phenyl Sepharose High Performance columns 
(GE Healthcare). The purified protein was stored in 25 mM Tris-Cl pH 8.0, 0.1 M 
ammonium sulphate before setting up for high-throughput crystallization using 
Mosquito liquid transfer robot (TTP Labtech). By use of sitting-drop vapour diffu-
sion method, crystals were obtained at room temperature by mixing 0.1 µl human 
SerRS (20 mg ml − 1, pre-incubated with 5 mM ATP and 10 mM MgCl2) and 0.1 µl 
reservoir solution (20% PEG 3350, 0.2 M tri-sodium citrate pH 7.0) equilibrated 
against 70 µl reservoir solution.
Crystal data collection and structure determination. Crystals were cryopro-
tected with 15% glycerol added to the reservoir solution and flash frozen with 
liquid nitrogen. A 2.9 Å resolution data set was collected at 100 K on beamline 
BL7-1 at Stanford Synchrotron Radiation Laboratory with an ADSC Q315 detector. 
The crystal belongs to space group P212121 with unit cell dimensions a = 116.80 Å, 
b = 189.42 Å and c = 230.59 Å. Diffraction data were processed, integrated and 
scaled with HKL200021. The structure of human SerRS was solved by molecular 
replacement using Pyrococcus horikoshii SerRS (PDB 2ZR3)22 structure as search 
model in program PHASER23 from the CCP4 package24. Three homodimers of 
SerRS were found in one asymmetric unit with ~55% solvent content25. Iterative 
model building and refinement were performed using Coot26 and Phenix27 with 
83% of the polypeptide chains resolved in the final model with Rwork of 20.8% and 
Rfree of 25.7% at 2.9 Å resolution.
HDX and mass spectrometry. SerRS mutant proteins were overexpressed and 
purified as described for the WT protein, and stored in 25 mM HEPES pH 7.5 
and 150 mM NaCl. To initiate the HDX reaction, 5 µl of SerRS protein (WT or 
F383V mutant) was incubated with 45 µl of DPBS buffer in D2O (2.6 µM final 
concentration) for 0.5, 1, 2, 4, 8, 15, 30, 60, 120 or 240 min, followed by simulta-
neous quench and proteolysis by addition of protease type XIII solution (three-
fold dilution from a saturated solution) in 1.0% formic acid, 40 mM TCEP and 
4 M urea28. The digested peptide fragments were separated by a fast LC gradient 
through a ProZap C18 column (Grace Davison, 1.5 µm, 500 Å, 2.1×10 mm) to 
minimize back exchange29. A post-column splitter reduced the LC eluent flow 
Table 1 | Statistics of ISV abnormal branching rescued by WT 
or mutant human SerRS mRNA injection.
Total  
(No.)
ISV  
abnormal (No.)
ISV  
abnormal (%)
uninjected 207 3 1.4
serRs-mo 189 96 50.8
serRs-mo + serRs (WT) 190 16 8.4
serRs-mo + serRs 
(∆482–514)
177 79 44.6
serRs-mo + serRs 
(nLsmut)
151 77 51.0
serRs-mo + serRs 
(F383 V)
153 69 45.1
serRs-mo + serRs 
(F383V/D378R)
153 13 8.5ARTICLE
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rate to ~400–500 nl min − 1 for efficient microelectrospray ionization  
(micro-ESI)30. Microelectrosprayed HDX samples were directed to a  
custom-built hybrid linear trap quadrupole 14.5-Tesla FT-ICR mass spectrom-
eter (ThermoFisher, San Jose, CA) for accurate mass measurement31. The total 
data acquisition period for each sample was 6 min. All experiments were per-
formed in triplicate. Data were analysed with a custom analysis package32 and a 
Python program33. Time-course deuterium incorporation levels were generated 
by an MEM fitting method34.
Active site titration assay. Active site titration assay was performed in  
100 mM HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2, 50 µM ATP, 22.2 nM  
[γ-32P]-ATP, 20 mM L-serine, 2 µg ml–1 pyrophosphatase (Roche) and 2 mM 
dithiothreitol (DTT) as previously described35 to determine the concentration  
of active enzymes.
ATP-PPi exchange assay. ATP-PPi exchange assay was performed with 0.5 µM 
SerRS (WT or mutants) in 100 mM HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2, 
2 mM ATP, 500 µM L-serine, 1 mM Na-PPi and 0.07 mCi Na-32PPi and 2 mM DTT 
as described35. The kinetics parameters of ATP and serine for each enzyme (WT at 
65 nM; F383V at 135 nM; ∆482–514 at 73 nM; NLSmut at 91 nM) were determined 
by varying the ATP and serine concentrations, respectively, while saturating the 
concentration of the other substrate.
In vitro transcription and purification of tRNAser. The tRNAser(AGA) coding 
sequence was cloned into pUC18 vector with a T7 promoter sequence at the 5′-end 
and a BstNI restriction enzyme site at the 3′-end to allow generation of a linear 
template that would give the correct 3′-CCA end in the tRNA transcript. In vitro  
transcription was performed in 40 mM Tris-Cl pH 8.0, 25 mM NaCl, 20 mM 
MgCl2, 1 mM spermidine, 2 µg ml − 1 pyrophosphatase, 0.1 mg ml − 1 bovine serum 
albumin, 5 mM DTT, NTPs with T7 polymerase and BstNI-linearized DNA  
template at 37 °C. The tRNA transcript was purified by Mono Q HR5/5 anion 
exchange column (GE Healthcare). The purified tRNA was annealed by heating  
up to 95 °C and then slowly cooled to room temperature.
Aminoacylation assay. Aminoacylation assays were performed as described35 
with 50-nM enzyme in 50 mM HEPES pH 7.5, 20 mM KCl, 10 mM MgCl2, 4 mM 
ATP, 2 µM [3H]-l-serine, 20 µM l-serine, 2 mM DTT, 0.1 mg ml − 1 bovine serum 
albumin, 4 µg ml − 1 pyrophosphatase (Roche) and 1 µM tRNAser transcript. Kinet-
ics parameters of tRNAser were determined by varying the tRNA concentration 
from 0.1×~10× Km for each enzyme.
In vivo studies in zebrafish. Transgenic Tg (Fli1a: EGFP) fish were maintained 
at 28.5 °C under continuous water flow and filtration with automatic control for 
a 14:10 h light/dark cycle. The night before injection, male and female fish were 
placed in a 1-l tank containing fish mating cage with an inner mesh and divider. 
Zebrafish embryos were obtained from natural spawning by removing the divider 
and stimulating with light. The embryos were kept at 28.5 °C before and after 
microinjection. The SerRS MO was injected into the yolk of 1- to 2-cell stage  
embryos at the dosage of 4~5 ng per embryo. The SerRS morpholino (5′-AG 
GAGAATGTGAACAAACCTGACAC-3′) was purchased from Gene Tools, LLC 
(Philomath, OR, USA). Capped mRNAs of WT or various human SerRS mutants 
were synthesized by use of the mMESSAGE mMACHINE (Ambion). Synthetic 
mRNAs were injected into the 1-cell stage embryos together with SerRS-MO 
at a dosage of ~250 pg per embryo. After injection, embryos were incubated in 
E3 embryo medium supplemented with 0.003% 1-phenyl-2-thiourea at 28.5 °C 
to prevent pigment formation. Embryos were anesthetized with 0.168 mg ml − 1 
tricaine (Sigma-Aldrich), mounted in 2% methylcellulose and photographed with 
a Nikon fluorescent microscope (AZ100) equipped with a Nikon CCD camera 
(Qimaging Retiga 2000R). All the experiments involving zebrafish had been con-
ducted according to the guidelines established by the Institutional Animal Care 
and Use Committee (IACUC) at The Scripps Research Institute, IACUC approval 
number 09-0009.
Reverse transcription PCR. Seventy-two hours after injection, ten zebrafish em-
bryos from each group were collected for total RNA extraction using Trizol reagent 
(Invitrogen) according to the manufacturer’s instruction. The total RNAs (1 µg 
for each group) were reverse transcribed by using M-MLV reverse transcriptase 
(Promega) and oligo dT(20) as the primer. The reverse transcription products  
were then used as templates for PCR reaction using the Taq DNA polymerase  
(Fermentas). The sequences of the primers for zebrafish vegfa are: 5′-GGCTCT 
CCTCCATCTGTCTGC-3′ (forward) and 5′-CAGTGGTTTTCTTTCTTTGC 
TTTG-3′ (reverse). The sequences of the primers for zebrafish β-actin are:  
5′-TCACCACCACAGCCGAAAGAG-3′ (forward) and 5′-GTCAGCAATGCCA 
GGGTACAT-3′ (reverse). Each PCR cycle includes denaturation at 95 °C for 30 s, 
annealing at 60 °C for 20 s and elongation at 72 °C for 20 s. We performed 28 cycles 
of PCR for the vegfa gene and 18 cycles for the β-actin gene. The PCR products 
were then analysed by agarose gel electrophoresis and visualized by ethidium 
bromide staining. The density of each band was semiquantificated on the gel image 
using Multi Gauge V3.0 software (Fujifilm). The relative expression levels of vegfa 
were determined after normalization to β-actin. 
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